Recent advances in CD8+ regulatory t cell research (Review)

95Citations
Citations of this article
245Readers
Mendeley users who have this article in their library.

Abstract

Various subgroups of CD8+ T lymphocytes do not only demonstrate cytotoxic effects, but also serve important regulatory roles in the body's immune response. In particular, CD8+ regulatory T cells (CD8+ Tregs), which possess important immunosuppressive functions, are able to effectively block the overreacting immune response and maintain the body's immune homeostasis. In recent years, studies have identified a small set of special CD8+ Tregs that can recognize major histocompatibility complex class Ib molecules, more specifically Qa-1 in mice and HLA-E in humans, and target the self-reactive CD4+ T cells. These findings have generated broad implications in the scientific community and attracted general interest to CD8+ Tregs. The present study reviews the recent research progress on CD8+ Tregs, including their origin, functional classification, molecular markers and underlying mechanisms of action.

Cite

CITATION STYLE

APA

Yu, Y., Ma, X., Gong, R., Zhu, J., Wei, L., & Yao, J. (2018, June 1). Recent advances in CD8+ regulatory t cell research (Review). Oncology Letters. Spandidos Publications. https://doi.org/10.3892/ol.2018.8378

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free